期刊文献+

HbA1C检测在肥胖儿童中诊断筛查糖代谢紊乱的效果 被引量:7

The validity of HbA1c detection in diagnosing and screening dysglycemia in children with obesity
原文传递
导出
摘要 评估应用美国糖尿病协会(ADA)近日推荐的HbA1c标准对早期探查肥胖儿童糖代谢紊乱的作用。293名肥胖儿童均行口服葡萄糖耐量试验(OGTT),以其工作特征曲线(ROC)评价空腹血糖(FPG)和HbA1c探查糖耐量异常的敏感性和特异性。结果显示,基于传统的血糖标准,本组研究对象2型糖尿病的患病率为3.8%、糖尿病前期的患病率为16.0%。加入HbA1c标准后有4.1%的患者符合2型糖尿病诊断、25.6%的患者可列人糖尿病高风险人群。以OGTT为金标准,HbA1c识别糖耐量异常的能力明显强于FPG,ROC曲线下面积分别为0.875和0.713(P〈0.01)。采用ADA推荐的HbA1c≥5.7%、FPG≥5.6mmol/L的切点识别糖耐量异常的敏感性和特异性分别为60.5%和86.8%、30.5%和94.0%。 The validity of the recently recommended HbA1c criterion by the American Diabetes Association (ADA) in identification of dysglycemia in children with obesity was evaluated. 293 obese children underwent oral glucose tolerance test. Receiver operating characteristic (ROC) curve analysis was used to examine the sensitivity and specificity of fasting plasma glucose (FPG) and HbA1c in identifying dysglycemia. The results showed that the prevalence of type 2 diabetes mellitus ( T2DM ) was 3.8% and prediabetes 16. 0% based on plasma glucose standard. 4. 1% and 25.6% were categorized as T2DM and "at high risk of diabetes mellitus" based on both HbA1c and plasma glucose criteria. HbA1c was more efficacious than FPG in detecting abnormal glucose tolerance as shown by the areas under the curve in ROC of 0. 875 and 0. 713 respectively(P〈0.01 ). The sensitivity and specificity were 60. 5% and 86. 8% at HbAlc ≥5.7%, and 30. 5% and 94.0% at FPG ≥ 5.6 mmol/L.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2011年第9期746-748,共3页 Chinese Journal of Endocrinology and Metabolism
关键词 糖化血红蛋白 肥胖儿童 糖尿病 2型 口服葡萄糖耐量试验 HbA1c Obese children Diabetes mellitus, type 2 Oral glucose tolerance test
  • 相关文献

参考文献2

二级参考文献46

  • 1中华医学会糖尿病学分会.中国2型糖尿病防治指南.中华内分泌代谢杂志,2008,24(2).
  • 2Thompson C J, Cummings JF, Chalmers J, et al. How have patients reacted to the implications of the DCCT? Diabetes Care, 1996,19:876- 879.
  • 3International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care ,2010,33:676-682.
  • 4International Diabetes Federation. Global Guideline on Pregnancy and Diabetes. 2009, http://www.idf. org/webdata/docs/Pregnancy_EN_RTP. pdf.
  • 5Oglesby AK, Secnik K, Barron J, et al. The association between diabetes related medical costs and glycemic control : a retrospective analysis. Cost Eft Resour Alloc ,2006,4 : 1-8.
  • 6Dowell MA, Rozell B, Roth D, et al. Economic and clinical disparities in hospitalized patients with type 2 diabetes. J Nuts Scholarsh,2004,36 : 66-72.
  • 7Bloomgarden ZY. A1C: recommendations, debates, and questions. Diabetes Care ,2009,32 : e141 -e147.
  • 8Steffes M, Molitch M, Chavers B, et al. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. J Am Med Assoc, 2003, 290: 2159-2167.
  • 9Shichiri M, Kishikawa H, Ohkubo Y, et al. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care,2000,2:21-29.
  • 10Hayden MR. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes( UKPDS 33 ). Lancet, 1998,352 : 837- 853.

共引文献2117

同被引文献87

  • 1高天理,张茁.卒中的预防重于治疗[J].北京医学,2005,27(11):674-677. 被引量:4
  • 2曹冰燕,米杰,巩纯秀,程红,颜纯,侯冬青,刘敏,桑艳梅,朱逞.北京市19593名儿童青少年糖尿病患病现况调查[J].中华流行病学杂志,2007,28(7):631-634. 被引量:29
  • 3李青,吴松华,潘洁敏,唐峻岭,张扬,陆惠娟,包玉倩,贾伟平,项坤三.酶法测定糖化血清白蛋白的初步评价[J].上海交通大学学报(医学版),2007,27(7):785-787. 被引量:4
  • 4Lobstein T,Baur L,Uauy R. Obesity in children and youngpeople: a crisis in public health [J]. Obes Rev, 2004, 5(Suppl1): 4-85.
  • 5Leite SA,Anderson RL, Kendall DM, et al. A1C Predictstype 2 diabetes and impaired glucose tolerance in a populationat risk: the community diabetes prevention project [J]. DiabetolMetab Syndr, 2009,1(1): 1-5.
  • 6Santos-Oliveira R, Purdy C,da Silva MP, et al HaemoglobinAle levels and subsequent cardiovascular disease in personswithout diabetes: a meta-analysis of prospective cohorts [J].Diabetologia, 2011,54(6): 1327-1334.
  • 7Lee HS,Park HK, Hwang JS. HbA(lc) and glucose intole-rance in obese children and adolescents [J]. Diabet Med,2012, 29(7): el02-105.
  • 8Park S, Barrett-Connor E,Wingard DL, et al. GHb is a betterpredictor of cardiovascular disease than fasting or postchal-lenge plasma glucose in women without diabetes. The RanchoBernardo Study [J]. Diabetes Care, 1996,19(5): 450-456.
  • 9Borg R, Kuenen JC, Carstensen B, et ah HbAlc and meanblood glucose show stronger associations with cardiovasculardisease risk factors than do postprandial glycaemia or glucosevariability in persons with diabetes: the AlC-Derived AverageGlucose (ADAG) study [J]. Diabetologia, 2011,54(1): 69-72.
  • 10Selvin E,Steffes MW, Zhu H, et al Glycated hemoglobin,diabetes, and cardiovascular risk in nondiabetic adults [J]. NEngl J Med, 2010, 362(9): 800-811.

引证文献7

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部